Description

Osimertinib is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). It works by inhibiting the activity of the mutated EGFR, thereby slowing down the growth of cancer cells.

Interpreter Notes

Interpreters should be aware that osimertinib may be referred to in various ways, including its brand name. It is crucial to maintain a formal register and ensure that the term used aligns with the clinical context to avoid confusion with other cancer therapies.

Example Sentences

EN: The oncologist prescribed Osimertinib for the patient's advanced lung cancer.

ES: El oncólogo recetó Osimertinib para el cáncer de pulmón avanzado del paciente.

Common Interpreter Mistakes

Confusing Osimertinib with other EGFR inhibitors; mispronouncing the term leading to misunderstanding; using informal language when discussing the medication.